USE OF FERROQUINE IN THE TREATMENT OF MALARIA

摘要

The present invention relates to the use of ferroquine or its N-demethylated metabolite or any of the pharmaceutically acceptable salts thereof for treating and/or preventing infections caused by the parasite Plasmodium vivax and, more generally, a parasite of the genus Plasmodium, the life cycle of which includes a phase of hepatic latency in the human host.